A proteomic comparison of immature and mature mouse gonadotrophs reveals novel differentially expressed nuclear proteins that regulate gonadotropin gene transcription and RNA splicing

Biology of Reproduction

Volumn 79, Issue 3, 2008, Pages 546-561

  Feng, Jiajun ^a   Lawson, Mark A ^a   Melamed, Philippa ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Differentiation; Follicle stimulating hormone; Gonadototroph; Gonadotropins; Luteinizing hormone; Pituitary; Proteomics

Indexed keywords

ACTIVIN; EUKARYOTIC TRANSLATION INITIATION FACTOR 4A ISOFORM; FOLLICLE STIMULATING HORMONE BETA POLYPEPTIDE; GONADOTROPIN; LUTEINIZING HORMONE BETA SUBUNIT; MITOGEN ACTIVATED PROTEIN KINASE; PRE MRNA PROCESSING FACTOR 19 HOMOLOG; PROHIBITIN; RIBONUCLEOPROTEIN; TRANSCRIPTION FACTOR; TRANSGELIN; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; GENE CONTROL; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; GONADOTROPIN SECRETING CELL; HUMAN; HUMAN CELL; INTRON; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RNA SPLICING;

ALTERNATIVE SPLICING; ANIMALS; CELL DIFFERENTIATION; CELL NUCLEUS; CELLS, CULTURED; DNA REPAIR ENZYMES; EUKARYOTIC INITIATION FACTOR-4A; GENE EXPRESSION REGULATION; GONADOTROPHS; GONADOTROPINS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; MICE; NUCLEAR MATRIX-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEOMICS; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 50849133904     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.108.068106     Document Type: Article

References (80)

1. Alarid ET, Windle JJ, Whyte DB, Mellon PL. Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice. Development 1996; 122:3319-3329.
2. Jorgensen JS, Quirk CC, Nilson JH. Multiple and overlapping combinatorial codes orchestrate hormonal responsiveness and dictate cell-specific expression of the genes encoding luteinizing hormone. Endocr Rev 2004; 25:521-542.
3. Melamed P, Abdul Kadir MN, Wijeweera A, Seah S. Transcription of gonadotropin β subunit genes involves cross-talk between the transcription factors and co-regulators that mediate actions of the regulatory hormones. Mol Cell Endocrinol 2006; 252:167-183.
4. Lim S, Koh M, Luo M, Yang M, Abdul Kadir MN, Tan JH, Ye Z, Wang W, Melamed P. Distinct mechanisms involving diverse histone deacetylases repress expression of the two gonadotropin β-subunit genes in immature gonadotropes, and their actions are overcome by GnRH. Mol Cell Biol 2007; 27:4105-4120.
5. Graham KE, Nusser KD, Low MJ. LβT2 gonadotroph cells secrete follicle stimulating hormone (FSH) in response to activinA. J Endocrinol 1999; 162:R1-R5.
6. Pernasetti F, Vasilyev VV, Rosenberg SB, Bailey JS, Huang HJ, Miller WL, Mellon PL. Cell-specific transcriptional regulation of follicle-stimulating hormone β by activin and gonadotropin-releasing hormone in the LβT2 pituitary gonadotrope cell model. Endocrinology 2001; 142:2284-2295.
7. Wurmbach E, Yuen T, Ebersole BJ, Sealfon SC. Gonadotropin-releasing hormone receptor-coupled gene network organization. J Biol Chem 2001; 276:47195-47201.
8. Ruf F, Fink MY, Sealfon SC. Structure of the GnRH receptor-stimulated signaling network: insights from genomics. Front Neuroendocrinol 2003; 24:181-199.
9. Ruf F, Park MJ, Hayot F, Lin G, Roysam B, Ge YC, Sealfon SC. Mixed analog/digital gonadotrope biosynthetic response to gonadotropin-releasing hormone. J Biol Chem 2006; 281:30967-30978.
10. Ruf F, Sealfon SC. Genomics view of gonadotrope signaling circuits. Trends Endocrinol Metab 2004; 15:331-338.
11. Kakar SS, Winters SJ, Zacharias W, Miller DM, Flynn S. Identification of distinct gene expression profiles associated with treatment of LβT2 cells with gonadotropin-releasing hormone agonist using microarray analysis. Gene 2003; 308:67-77.
12. Zhang H, Bailey JS, Coss D, Lin B, Tsutsumi R, Lawson MA, Mellon PL, Webster NJG. Activin modulates the transcriptional response of LβT2 cells to gonadotropin-releasing hormone and alters cellular proliferation. Mol Endocrinol 2006; 20:2909-2930.
13. Lawson MA, Tsutsumi R, Zhang H, Talukdar I, Butler BK, Santos SJ, Mellon PL, Webster NJG. Pulse sensitivity of the luteinizing hormone β promoter is determined by a negative feedback loop involving early growth response-1 and Ngfi-A binding protein 1 and 2. Mol Endocrinol 2007; 21:1175-1191.
14. Luo M, Koh M, Feng J, Wu Q, Melamed P. Cross-talk in hormonally-regulated gene transcription through induction of estrogen receptor ubiquitylation. Mol Cell Biol 2005; 25:7386-7398.
15. Quirk CC, Seachrist DD, Nilson JH. Embryonic expression of the luteinizing hormone β gene appears to be coupled to the transient appearance of p8, a high mobility group-related transcription factors. J Biol Chem 2003; 278:1680-1685.
16. Mohammad HP, Seachrist DD, Quirk CC, Nilson JH. Reexpression of p8 contributes to tumorigenic properties of pituitary cells and appears in a subset of prolactinomas in transgenic mice that hypersecrete luteinizing hormone. Mol Endocrinol 2004; 18:2583-2593.
17. Melamed P, Koh M, Preklathan P, Bei L, Hew CL. Multiple mechanisms for Pitx-1 transactivation of a luteinizing hormone β subunit gene. J Biol Chem 2002; 277:26200-26207.
18. Melamed P, Xue YK, Poon JF, Wu Q, Xie H, Yeo J, Foo TW, Chua HK. The male seahorse synthesizes and secretes a novel C-type lectin into the brood pouch during early pregnancy. FEBS J 2005; 272:1221-1235.
19. Pappin DJC, Hojrup P, Bleasby AJ. Rapid identification of proteins by peptide-mass fingerprinting. Current Biology 1993; 3:327-332.
20. Niranjanakumari S, Lasda E, Brazas R, Garcia-Blanco MA. Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods 2002; 26:182-190.
21. Schoderbek WE, Kim KE, Ridgway EC, Mellon PL, Maurer RA. Analysis of DNA sequences required for pituitary-specific expression of the glycoprotein hormone alpha-subunit gene. Mol Endocrinol 1992; 6:893-903.
22. Heckert LL, Schultz K, Nilson JH. Different composite regulatory elements direct expression of the human α subunit gene to pituitary and placenta. J Biol Chem 1995; 270:26497-26504.
23. Herbert BR, Molloy MP, Gooley AA, Walsh BJ, Bryson WG, Williams KL. Improved protein solubility in two-dimensional electrophoresis using tributyl phosphine as reducing agent. Electrophoresis 1998; 19:845-851.
24. Jupe E, Liu XT, Kiehlbauch JL, McClung JK, Dell'Orco RT. The 3′untranslated region of prohibitin and cellular immortalization. Exp Cell Res 1996; 224:128-135.
25. Manjeshwar S, Branam DE, Lerner MR, Brackett DJ, Jupe ER. Tumor suppression by the prohibitin gene 3′untranslated region RNA in human breast cancer. Cancer Res 2003; 63:5251-5256.
26. Hutchison S, LeBel C, Blanchette M, Chabot B. Distinct sets of adjacent heterogeneous nuclear ribonucleoprotein (HNRNP) A1/A2 biding sites control 5′ splice site selection in the HNRNP A1 mRNA precursor. J Biol Chem 2002; 277:29745-29752.
27. Choong ML, Tan LK, Lo SL, Ren EC, Ou K, Ong SE, Liang RCMY, Seow TK, Chung MCM. An integrated approach in the discovery and characterization of a novel nuclear protein over-expressed in liver and pancreatic tumors. FEBS Lett 2001; 496:109-116.
28. Fukuda S, Wu DW, Stark K, Pelus LM. Cloning and characterization of a proliferation-associated cytokine-inducible protein, CIP29. Biochem Biophys Res Commun 2002; 292:593-600.
29. Leaw CL, Ren EC, Choong ML. Hcc-1 is a novel component of the nuclear matrix with growth inhibitory function. Cell Mol Life Sci 2004; 61:2264-2273.
30. Fukuda S, Pelus LM. Growth inhibitory effect of Hcc-1/CIP29 is associated with induction of apoptosis, not just with G(2)/M arrest. Cell Mol Life Sci 2005; 62:1526-1527.
31. Aravind L, Koonin EV. SAP - a putative DNA-binding motif involved in chromosomal organization. Trends Biochem Sci 2000; 25:112-114.
32. Sugiura T, Sakurai K, Nagano Y. Intracellular characterization of DDX39, a novel growth-associated RNA helicase. Exp Cell Res 2007; 313:782-790.
33. Rajalingam K, Rudel T. Ras-Raf signaling needs prohibitin. Cell Cycle 2005; 4:1503-1505.
34. Rajalingam K, Wunder C, Brinkmann V, Churin Y, Hekman M, Sievers C, Rapp UR, Rudel T. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nature Cell Biol 2005; 7:837-843.
35. Grosse R, Roelle S, Herrlich A, Hohn J, Gudermann T. Epidermal growth factor receptor tyrosine kinase mediates Ras activation by gonadotropin- releasing hormone. J Biol Chem 2000; 275:12251-12260.
36. Benard O, Naor Z, Seger R. Role of dynamin, Src, and Ras in the protein kinase C-mediated activation of ERK by gonadotropin-releasing hormone. J Biol Chem 2001; 276:4554-4563.
37. Naor Z, Bernard O, Seger R. Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor. Trends Endocrinol Metab 2000; 11:91-99.
38. Mishra S, Murphy LC, Murphy LJ. The prohibitins: emerging roles in diverse functions. J Cell Mol Med 2006; 10:353-363.
39. Wang S, Fusaro G, Padmanabhan J, Chellappan SP. Prohibitin colocalizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene 2002; 21:8388-8396.
40. Wang S, Zhang B, Faller DV. BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists. EMBO J 2004; 23:2293-2303.
41. Wang S, Nath N, Adlam M, Chellappan SP. Prohibitin, a potential tumor suppressor, interacts with Rb and regulates E2F function. Oncogene 1999; 18:3501-3510.
42. Rastogi S, Joshi B, Dasgupta P, Morris M, Wright K, Chellappan SP. Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes. Mol Cell Biol 2006; 26:4161-4171.
43. Krecic AM, Swanson MS. HNRNP complexes: composition, structure, and function. Curr Opin Cell Biol 1999; 11:363-371.
44. Munro TP, Magee RJ, Kidd GJ, Carson JH, Barbarese E, Smith LM, Smith R. Mutational analysis of a heterogeneous nuclear ribonucleoprotein A2 response element for RNA trafficking. J Biol Chem 1999; 274:34389-34395.
45. Hou VC, Lersch R, Gee SL, Ponthier JL, Wu M, Turck CW, Koury M, Krainer AR, Mayeda A, Conboy JG. Decrease in HNRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch. EMBO J 2002 21:6195-6204.
46. Buratti E, Baralle FE. Influence of RNA secondary structure on the pre-mRNA splicing process. Mol Cell Biol 2004; 24:10505-10514.
47. van Oordt WV, Diaz-Meco MT, Lozano J, Krainer AR, Moscat J, Caceres JE. The MKK3/6-p38-signaling cascade alters the subcellular distribution of HNRNP A1 and modulates alternative splicing regulation. J Cell Biol 2000; 149:307-316.
48. Black DL. Mechanisms of alternative pre-messenger RNA splicing. Ann Rev Biochem 2003; 72:291-336.
49. Montuenga LM, Zhou J, Avis I, Vos M, Martinez A, Cuttitta F, Treston AM, Sunday M, Mulshine JL. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 changes with critical stages of mammalian lung development. Am J Respir Cell Mol Biol 1998; 19:554-562.
50. Umar A, Ooms MP, Luider TM, Grootegoed JA, Brinkmann AO. Proteomic profiling of epididymis and vas deferens: identification of proteins regulated during rat genital tract development. Endocrinology 2003; 144:4637-4647.
51. Zhou J, Mulshine JL, Unsworth EJ, Scott FR, Avis IM, Vos MD, Treston AM. Purification and characterization of a protein that permits early detection of lung cancer - identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4. J Biol Chem 1996; 271:10760-10766.
52. Zhou J, Allred DC, Avis I, Martinez A, Vos MD, Smith L, Treston AM, Mulshine JL. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (HNRNP-A2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res Treat 2001; 66:217-224.
53. Lee CH, Lum JHK, Cheung BPY, Wong MS, Butt YKC, Tam MF, Chan WY, Chow C, Hui PK, Kwok FSL, Lo SCL, Fan DM. Identification of the heterogeneous nuclear ribonucleoprotein A2/B1 as the antigen for the gastrointestinal cancer specific monoclonal antibody MG7. Proteomics 2005; 5:1160-1166.
54. Holzmann K, Gerner C, Poltl A, Schafer R, Obrist P, Ensinger C, Grimm R, Sauermann G. A human common nuclear matrix protein homologous to eukaryotic translation initiation factor 4A. Biochem Biophys Res Commun 2000; 267:339-344.
55. Palacios IM, Gatfield D, St Johnston D, Izaurralde E. An eIF4AIII-containing complex required for mRNA localization and nonsense-mediated mRNA decay. Nature 2004; 427:753-757.
56. Shibuya T, Tange TO, Sonenberg N, Moore MJ. eIF4AIII binds spliced mRNA in the exon junction complex and is essential for nonsense-mediated decay. Nature Struct Mol Biol 2004; 11:346-351.
57. Ferraiuolo MA, Lee CS, Ler LW, Hsu JL, Costa-Mattioli M, Luo MJ, Reed R, Sonenberg N. A nuclear translation-like factor elF4AIII is recruited to the mRNA during splicing and functions in nonsense-mediated decay. Proc Natl Acad Sci U S A 2004; 101:4118-4123.
58. Ballut L, Marchadier B, Baguet A, Tomasetto C, Seraphin B, Le Hir H. The exon junction core complex is locked onto RNA by inhibition of eIF4AIII ATPase activity. Nature Struct Mol Biol 2005; 12:861-869.
59. Andersen CBF, Ballut L, Johansen JS, Chamieh H, Nielsen KH, Oliveira CLP, Pedersen JS, Seraphin B, Le Hir H, Andersen GR. Structure of the exon junction core complex with a trapped DEAD-box ATPase bound to RNA. Science 2006; 313:1968-1972.
60. Weinstein DC, Honore E, Hemmati-Brivanlou A. Epidermal induction and inhibition of neural fate by translation initiation factor 4AIII. Development 1997; 124:4235-4242.
61. Weiss J, Guendner MJ, Halvorson LM, Jameson JL. Transcriptional activation of the follicle stimulating hormone β subunit gene by activin. Endocrinology 1995; 136:1885-1891.
62. Suszko MI, Lo DJ, Suh H, Camper SA, Woodruff TK. Regulation of the rat follicle-stimulating hormone β-subunit promoter by activin. Mol Endocrinol 2003; 17:318-332.
63. Bernard DJ. Both SMAD2 and SMAD3 mediate activin-stimulated expression of the follicle-stimulating hormone β subunit in mouse gonadotrope cells. Mol Endocrinol 2004; 18:606-623.
64. Chen CH, Yu WC, Tsao TY, Wang LY, Chen HR, Lin JY, Tsai WY, Cheng SC. Functional and physical interactions between components of the Prp19p-associated complex. Nucleic Acids Res 2002; 30:1029-1037.
65. Grillari J, Ajuh P, Stadler G, Loscher M, Voglauer R, Ernst W, Chusainow J, Eisenhaber F, Pokar M, Fortschegger K, Grey M, Lamond AI, et al. SNEV is an evolutionarily conserved splicing factor whose oligomerization is necessary for spliceosome assembly. Nucleic Acids Res 2005; 33:6868-6883.
66. Stamm S. Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. Hum Mol Genet 2002; 11:2409-2416.
67. Maniatis T, Reed R. An extensive network of coupling among gene expression machines. Nature 2002; 416:499-506.
68. Orphanides G, Reinberg D. A unified theory of gene expression. Cell 2002; 108:439-451.
69. Hofmann WA, Stojiljkovic L, Fuchsova B, Vargas GM, Mavrommatis E, Philimonenko V, Kysela K, Goodrich JA, Lessard JL, Hope TJ, Hozak P, de Lanerolle P. Actin is part of pre-initiation complexes and is necessary for transcription by RNA polymerase II. Nature Cell Biol 2004; 6:1094-1101.
70. Kukalev A, Nord Y, Palmberg C, Bergman T, Percipalle P. Actin and HNRNP U cooperate for productive transcription by RNA polymerase II. Nature Struct Mol Biol 2005; 12:238-244.
71. Fomproix N, Percipalle P. An actin-myosin complex on actively transcribing genes. Exp Cell Res 2004; 294:140-148.
72. Gettemans J, Van Impe K, Delanote V, Hubert T, Vandekerckhove J, De Corte V. Nuclear actin-binding proteins as modulators of gene transcription. Traffic 2005; 6:847-857.
73. Lewis SA, Lee MG, Cowan NJ. Five mouse tubulin isotypes and their regulated expression during development. J Cell Biol 1985; 101:852-861.
74. Shapland C, Hsuan JJ, Totty NF, Lawson D. Purification and properties of transgelin - a transformation and shape change sensitive actin-gelling protein. J Cell Biol 1993; 121:1065-1073.
75. Lawson D, Harrison M, Shapland C. Fibroblast transgelin and smooth muscle SM22a are the same protein, the expression of which is down-regulated in many cell lines. Cell Motil Cytoskel 1997; 38:250-257.
76. Fu Y P, Liu HW, Forsythe SM, Kogut P, McConville JF, Halayko AJ, Camoretti-Mercado B, Solway J. Mutagenesis analysis of human SM22: characterization of actin binding. J Appl Physiol 2000; 89:1985-1990.
77. Kaplan-Albuquerque N, Garat C, Van Putten V, Nemenoff RA. Regulation of SM22α expression by arginine vasopressin and PDGF-BB in vascular smooth muscle cells. Am J Physiol Heart Circ 2003; 285:H1444-H1452.
78. Nair RR, Solway J, Boyd DD. Expression cloning identifies transgelin (SM22) as a novel repression of 92-kDa type IV collagenase (MMP-9) expression. J Biol Chem 2006; 281:26424-26436.
79. Melamed P, Zhu Y, Tan SH, Xie M, Koh M. Gonadotropin releasing hormone activation of c-jun, but not Egr-1, stimulates transcription of a luteinizing hormone β subunit gene. Endocrinology 2006; 147:3598-3605.
80. Coss D, Jacobs SBR, Bender CE, Mellon PL. A novel AP-1 site is critical for maximal induction of the follicle-stimulating hormone β gene by gonadotropin-releasing hormone. J Biol Chem 2004; 279:152-162.